GWASs for AD have revealed novel pathways associated with AD, including in lipid metabolism, immune responses, and endocytosis, while also finding no enrichment of genes associated with either tau or amyloid pathways, suggesting other factors may play a role in risk and development of AD (7). The gene discussed is MAPT; the disease is Alzheimer disease.